CARBOGEN AMCIS Sitemap
- Knowledge Centre & Open Positions
- Articles
- Antibody Drug Conjugates and Bioconjugation made in Bubendorf
- CARBOGEN AMCIS 2023 Spring Science Day Event
- CARBOGEN AMCIS Apprenticeship Diaries - Eveline
- CARBOGEN AMCIS Apprenticeship Diaries - Philip
- CARBOGEN AMCIS Veenendaal - Solvent-free in 2030?
- Chromatography Services offered in Switzerland
- Custom Development and Manufacture of Fine Chemicals
- Data Integrity: A Key Topic for CARBOGEN AMCIS as a leading API Supplier
- Highly Potent Active Pharmaceutical Ingredients at CARBOGEN AMCIS
- Interview Chemtogether 2017 Dr. Jonas Bürgler
- Interview Chemtogether 2021 Dr. Volker Wolfart
- Interview Chemtogether 2022 Dr. Luca Mannocci
- Interview For Chemtogether 2019 Dr. Volker Wolfart
- Interview with Emad El Sayed, Ph.D.
- Investigating Human Error in Pharmaceutical Manufacturing
- Our approach in Drug Product Development & Manufacture
- Process Development in China at CARBOGEN AMCIS + Case Study
- Q&A with Cor Veldhuizen, CARBOGEN AMCIS’ Global Head of Vitamin D analogues
- Saint-Beauzire: opening ceremony of our new site in France dedicated to Drug Products
- Brochures
- Careers
- Bring your future to life at CARBOGEN AMCIS: we're hiring!
- CARBOGEN AMCIS Apprenticeship Diaries - Eveline
- CARBOGEN AMCIS Apprenticeship Diaries - Philip
- Interview Chemtogether 2017 Dr. Jonas Bürgler
- Interview Chemtogether 2021 Dr. Volker Wolfart
- Interview For Chemtogether 2019 Dr. Volker Wolfart
- Interview with Emad El Sayed, Ph.D.
- Q&A with Cor Veldhuizen, CARBOGEN AMCIS’ Global Head of Vitamin D analogues
- Case Studies
- Expansion News
- "140 neue Jobs am Standort Hunzenschwil"
- "CARBOGEN AMCIS accélère dans le domaine du médicament injectable"
- "CARBOGEN AMCIS développe des médicaments injectables"
- "CARBOGEN AMCIS lance une nouvelle unité de fabrication de produits injectables"
- "CARBOGEN AMCIS to expand pharmaceutical services in Europe"
- "Der lange Weg zur Chemiefabrik in Hunzenschwil"
- "Dreistellige Millioneninvestition"
- "Les travaux de la nouvelle usine pharmaceutique CARBOGEN AMCIS"
- CARBOGEN AMCIS expands capacity for parenteral drug manufacturing
- CARBOGEN AMCIS Virtual DCAT Member Company Announcement Forum - Mark Griffiths
- Ground breaking Riom 2, France
- New Drug Products Facility
- Radio SRF1 - Regionaljournal Aargau Solothurn
- Saint-Beauzire: opening ceremony of our new site in France dedicated to Drug Products
- Teaser Riom 2 - Episode 2: The work is continuing
- Teaser Riom 2 project - Work has begun
- Open Positions
- Senior Chemist QC&A (m/w/d)
- (Senior) Chemist QS (m/w/d)
- Account Manager (m/f/d)
- Accountant (m/f/d)
- Assistante administrative et RH (H/F) – CDI – ST BEAUZIRE
- Chemie- und Pharmatechnologe / Chemikant (m/w/d)
- Chemie- und Pharmatechnologe/ Chemikant (m/w/d)
- Chemie- und Pharmatechnologe/ Chemikant (m/w/d)
- Chemikant oder Chemielaborant Chromatography Services (m/w/d)
- Chemist QA (m/w/d)
- Chemist QC&A (m/w/d)
- Consultant interne Supply Chain / Material H/F - CDI - Riom (63)
- Documentaliste Assurance Qualité (H/F) – CDD – RIOM
- Expert Production QA (m/w/d)
- Financieel Analist
- Global HR Manager (m/f/d)
- Head of Regulatory Affairs & CMC (m/f/d)
- Human Resources Assistant (m/w/d)
- IT Service Desk Specialist (m/w/d)
- Kilo Lab Operator
- Laboratory Technician QC&A (m/w/d)
- Lehrstelle Chemie- und Pharmatechnologe/-login EFZ (m/w/d)
- Lehrstelle Fachmann/Fachfrau Betriebsunterhalt EFZ Fachrichtung Hausdienst (w/m/d)
- Lehrstelle Fachmann/Fachfrau Logistiker/in EFZ, Fachrichtung Lager (m/w/d)
- Lehrstelle Kauffrau/Kaufmann EFZ, Dienstleistung & Administration (w/m/d)
- Lernende (m/w/d) für den Beruf des Laboranten EFZ Fachrichtung Chemie
- Manager IT Service Desk (m/w/d)
- Musterzieher QC&A (m/w/d)
- Project Manager 项目经理
- Projektleiter Verfahrenstechnik (m/w/d)
- QA Officer / Validatie Specialist
- QC&A Chemist
- Quality Control (QC) Chemist
- Quality Control Manager
- Responsable Assurance Qualité Opérationnelle (H/F) – CDI – ST BEAUZIRE
- Responsable informatique local H/F – CDI - Saint-Beauzire
- Reviewer und Compliance Expert QC&A (m/w/d)
- Senior Chemist / Project Chemist Chromatography Services (m/w/d)
- Senior Development Chemist
- Senior Labtechnician PR&D (m/w/d)
- Software-ProgrammiererIn und QualifiziererIn (m/f/d)
- Team Lead QC&A (m/w/d)
- Technicien(ne) Contrôle Qualité Chimie (H/F) – CDI – ST BEAUZIRE
- Press Mentions
- "140 neue Jobs am Standort Hunzenschwil"
- "CARBOGEN AMCIS accélère dans le domaine du médicament injectable"
- "CARBOGEN AMCIS développe des médicaments injectables"
- "CARBOGEN AMCIS lance une nouvelle unité de fabrication de produits injectables"
- "CARBOGEN AMCIS to expand pharmaceutical services in Europe"
- "Der lange Weg zur Chemiefabrik in Hunzenschwil"
- "Dreistellige Millioneninvestition"
- "Grosse Investitionen im Kampf gegen Krebs"
- "How the drug services industry found itself prepared for a pandemic"
- "Les travaux de la nouvelle usine pharmaceutique CARBOGEN AMCIS"
- 5 Minutes Interview with Dishman CARBOGEN AMCIS
- Chemical & Engineering News - "Pharmaceutical Outsourcing"
- Interview with Mark Griffiths – Group CEO, Dishman Group
- Making a step change
- Panel Discussion on Flow Chemistry
- Panel Discussion on Flow Chemistry
- Panel discussion on HPAPIs - Chemistry Today September/October 2022
- Pharma's Almanac
- Radio SRF1 - Regionaljournal Aargau Solothurn
- Regierungsrat Basel-Landschaft besucht die CARBOGEN AMCIS AG
- Regierungsrat Dieter Egli visits CARBOGEN AMCIS in Hunzenschwil
- Scientific Publications
- 2-(Diethylamino)ethanethiol
- A bridgehead amine with planar nitrogens
- Cage-like molecules with triple bonds
- Chiroptical Properties of some Monoazapentahelicenes
- Example of a Stereoselective Synthesis in Industrial API Manufacture
- HMG-CoA Reductase Inhibitor
- Identification of a 1,2,4,5-Tetraoxane Antimalarial Drug-Development Candidate
- Large scale preparation of 3-Methyl-4H-[ 1, 2, 4]oxadiazol-5-one
- Mastering the Supply Chain
- Process Development and Multikilogram Syntheses of XL228
- Process Optimization for GSK369796 (N-tert-Butyl Isoquine)
- Process scale-up of cis-N-Benzyl-3-methylamino-4-methylpiperidine
- Reaction of N,N'-bridged 1,10-diazacyclooctadeca-5,14-diynes with [ CpCo(cod)]
- Reactions of 1,8‐Diheterocyclotetradeca‐4,11‐diynes
- Safety Assessment for the Scale-up of an Oxime Reduction
- Scale-up of a high temperature Claisen synthesis
- Syntheses and properties of N,N′-bridged-1,10-diazabicyclooctadeca-5,14-diynes
- Synthesis and Structural Properties of Bridged 1,8‐Diazacyclotetradeca‐4,11‐diynes
- Synthesis of (S)-1-Boc-2,5-dihydro-1H-pyrrole-2- carboxylic Acid
- Synthesis of 2-Amino-8-hydroxyquinoline
- Videos
- Bring your future to life at CARBOGEN AMCIS: we're hiring!
- CARBOGEN AMCIS Drug Products New Site: Opening Ceremony video
- CARBOGEN AMCIS Passion For Science
- CARBOGEN AMCIS Virtual DCAT Member Company Announcement Forum - Mark Griffiths
- Customer Journey at CARBOGEN AMCIS
- Interview Nobel Laureate Prof. Lehn
- Interview Pascal Villemagne, VP Sales and Marketing at CARBOGEN AMCIS, for "Paroles d'experts"
- New Drug Products Facility
- Our locations and services in video
- Teaser Riom 2 - Episode 2: The work is continuing
- Teaser Riom 2 project - Work has begun
- Articles
- News & Events
- News
- CARBOGEN AMCIS opens new state-of-the-art facility dedicated to sterile liquid drug product manufacturing in France
- CARBOGEN AMCIS announces successful Swissmedic inspection at Vionnaz, Switzerland
- CARBOGEN AMCIS appointed new Vice President of Business Development, Sales & Marketing
- Pascal Villemagne appointed new CARBOGEN AMCIS Chief Executive Officer (CEO)
- Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on Clinical Research Study that reveals positive response in vitamin D deficiency/insufficiency in patients with COVID-19
- NH TherAguix announces the release of a new clinical batch for its drug AGuIX, manufactured by CARBOGEN AMCIS
- CARBOGEN AMCIS announces successful FDA inspection of its facility in Aarau, Switzerland
- CARBOGEN AMCIS announces a co-investment agreement of more than CHF 4 million with a long-standing Europe-based client
- Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on study that uncovers treatment for vitamin D deficiency (2)
- CARBOGEN AMCIS announces a co-investment agreement of more than CHF 15 million with a key client to expand Swiss site
- CARBOGEN AMCIS acquires new property at Bubendorf site
- CARBOGEN AMCIS announces major investments of more than CHF 100 million in Switzerland and France
- COVID-19
- Successful FDA Inspection at Neuland, Switzerland
- ISO22716 Cosmetics GMP standard accreditation
- Dishman Carbogen Amcis Opens Office in Kyoto, Japan
- CARBOGEN AMCIS Announces a Successful Swissmedic Inspection of its Site in Vionnaz, Switzerland
- CARBOGEN AMCIS AG Makes Capital Investments in ADC
- CARBOGEN AMCIS AG Continues to Invest in Expanding High Potency Capabilities
- CARBOGEN AMCIS Expands Operations in Switzerland
- CARBOGEN AMCIS CEO Mark Griffiths Appointed to Dishman Board of Directors
- CARBOGEN AMCIS Passes Successful Inspection by Swissmedic
- CARBOGEN AMCIS Expands Operations in Bubendorf
- CARBOGEN AMCIS Sites at Aarau and Neuland in Switzerland Successfully Pass FDA Inspection
- Dishman Celebrates a Decade of Success Since Acquisition of CARBOGEN AMCIS
- CARBOGEN AMCIS Sites at Bubendorf, Aarau and Neuland in Switzerland Successfully Pass Swissmedic Inspection
- CARBOGEN AMCIS Announces a Successful FDA Inspection of its Headquarters Site in Bubendorf, Switzerland
- News
© 2018 CARBOGEN AMCIS - All rights reserved
